Clinical Trials Logo

Motor Development clinical trials

View clinical trials related to Motor Development.

Filter by:
  • None
  • Page 1

NCT ID: NCT06186323 Completed - Clinical trials for Congenital Muscular Torticollis

Relationship Between Home Environment and Development in Children Diagnosed With Muscular Torticollis

Start date: December 10, 2023
Phase:
Study type: Observational

Congenital muscular torticollis (CMT) is a common postural deformity that occurs shortly after birth and is typically characterized by ipsilateral cervical lateral flexion and contralateral cervical rotation due to unilateral shortening of the sternocleidomastoid (SKM) muscle. It is a non-neurological postural disorder that generally affects 3% to 16% of babies. Theories such as intrauterine stenosis, vascular causes, fibrosis of the peripartum bleeding area, difficult birth, and primary myopathy of the SCM muscle have been put forward for its causes.Head position; It is thought that it may cause a negative impact on posture control and movement development, sensorimotor coordination, and retardation in gross motor function by affecting the shoulder, rib cage and abdominal muscles. Motor skills and sensory experiences begin to develop after birth and development continues as children grow. Having good motor control also helps children explore the world around them, which can help many other areas of development. There are many environmental and biological factors that affect motor development. In particular, the home environment, where the child spends most of his time, is one of the key factors affecting motor development. The home environment is known to be a very important factor for motor development in babies. At the same time, the variety of equipment and environmental conditions help children provide different sensory experiences. Since it is a common practice for physiotherapists to advise patients on home activities, exploring the home environment can have important effects on development. For these reasons, it was thought that the motor development and sensory processing suggestions given in the home environment for children diagnosed with torticollis would be supported by home environment opportunities.

NCT ID: NCT05948176 Not yet recruiting - Motor Development Clinical Trials

Motor Development of Normal Children

Start date: May 1, 2024
Phase:
Study type: Observational

The goal of this type of study: observational study is to compare motor development between urban and rural regions in pre-school age children. The main questions it aims to answer are: - Is there difference in gross motor development of normal children aged from four to six years between urban and rural areas? - Is there difference in fine motor development of normal children aged from four to six years between urban and rural areas? Participants will be asked to perform tasks of bruininks-oseretsky test of motor proficiency, second edition. Researchers will compare urban group and rural group to see if there is any difference in motor development.

NCT ID: NCT04889027 Completed - Clinical trials for Infant, Premature, Diseases

Standardized Infant NeuroDevelopmental Assessment (SINDA) in 0-24 Months Age in Turkey

Start date: July 17, 2020
Phase:
Study type: Observational

This study aims to assess Turkish validity and reliability of Standardized Infant Neurodevelopmental Assessment and to spread its use for evaluation in early rehabilitation in our country.

NCT ID: NCT04886310 Completed - Clinical trials for Infant, Premature, Diseases

Peabody Developmental Motor Scale-2 in 0 - 24 Months in Turkey

Start date: September 10, 2020
Phase:
Study type: Observational

This study is the determination of the Turkish version of the Peabody Developmental Motor Scale-2 and its Turkish validity reliability in infants age between 0 - 24 months and to spread its use for evaluation in early rehabilitation in our country.

NCT ID: NCT03999619 Completed - Physical Activity Clinical Trials

Evaluation of the Move 2 Learn (M2L) Program for Young Children

Start date: January 7, 2019
Phase: N/A
Study type: Interventional

Move 2 Learn (M2L) is a 10-week movement and pre-literacy program for preschool aged children and their parents designed to improve both movement and reading skills as well as support their overall cognitive, physical, and psychological development. This study will be using a randomized wait-list controlled trial design to evaluate the program on several outcomes: motor skills, pre-literacy skills, cognitive function, perceived physical competence, and physical activity. Children ages 3 to 4 years with typical development will be randomized to either start the program immediately or enter the wait-list control group to begin the program after a 10-week control period. The outcomes will be assessed for all children three times, at week 0, week 11, and week 21 to evaluate change over time in both groups.

NCT ID: NCT03313427 Completed - Preterm Infant Clinical Trials

Early Physical Therapy Intervention in Preterm Infants

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

The hypothesis of this study is that early physical therapy intervention, initiated during the NICU stay and up to 2 months corrected age, based on the family-centered model, could promote preterm infants motor development in short-term (2 months corrected age) and long-term (8 months corrected age). There is a high evidence level of different systematic reviews, which support the effectivity of early intervention with preterm infants. The principal aim of this randomized controlled trial is to evaluate the effectiveness of early physiotherapy intervention to promote motor development in preterm infants at 2 and 8 months corrected age. The secondary purpose is to study the motor development of those preterm infants who received early physical therapy intervention.

NCT ID: NCT01640600 Completed - Motor Development Clinical Trials

Yale Pink and Blue Kids: Effects of Exposure During Pregnancy to Nicotine or Antidepressants in 4-8 Year Old Children

PABKids
Start date: October 2011
Phase: N/A
Study type: Observational

The purpose of this project is to conduct a follow-up study with women that had participated in the Yale Pink and Blue Study of depression in pregnancy and birth outcomes. The Yale Pink and Blue Kids Study is a follow-up study with the mothers and also with the children they were pregnant with in Yale Pink and Blue. These children are now between the ages of 4 and 8 years old, which is a perfect time to look at developmental outcomes in children. This study will look at children with exposure to nicotine or antidepressants during pregnancy, as well as children who were not exposed. The investigators hypothesis is that children who were exposed to either nicotine or antidepressants in pregnancy will have poorer developmental outcomes than children who were not exposed. The investigators are also interested in determining whether nicotine exposure or antidepressant exposure results in poorer outcomes. The investigators specific aims are: 1. To determine whether pre-school and school aged offspring exposed to maternal cigarette smoking or antidepressants during pregnancy are more likely to have social-emotional problems compared to children who were not exposed to cigarettes or antidepressants during pregnancy. 2. To determine whether pre-school and school aged children who were exposed to prenatal maternal cigarette smoking or antidepressants during pregnancy display cognitive impairments as compared to children who were not exposed to either prenatal maternal cigarette smoking or antidepressants. 3. To determine if pre-school and school aged children who were exposed to maternal prenatal cigarette smoking or antidepressants display impaired motor development as compared to children who were not exposed to maternal cigarette smoking or antidepressants in pregnancy.

NCT ID: NCT01166451 Completed - Clinical trials for Iron Deficiency Anemia

The Anemia Control Program: High or Low Iron Supplementation

Start date: September 1991
Phase: N/A
Study type: Interventional

The purpose of this clinical trial was to determine if high-iron or low-iron formula, containing an average of 12.7 mg/L or 2.3 mg/L respectively, had differing effects on iron status in infancy and on development longitudinally.